Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Astagraf XL, Prograf, and MMF in Renal Transplant Candidates Post-Sleeve Gastrectomy
NCT02221583Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- May 2014
- Primary completion
- Feb 2015
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in graft rejection, sponsored by University of Cincinnati. Started May 2014; status: completed.
02
Drugs
tacrolimus
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT02221583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02221583.